Latest News and Press Releases
Want to stay updated on the latest news?
-
Vera Therapeutics announces appointment of Nancy Boman as Chief Regulatory Officer and planned retirement of William Turner
-
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Vera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgAN
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Vera Therapeutics announces inducement grants Under Nasdaq Listing Rule 5635(c)(4).
-
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
-
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Vera Therapeutics Appoints Christopher Hite to Board of Directors